We classified patients into the "Consider AIH" and "Not Considered" groups according to the EASL criteria and further classified AMA-M2–positive patients into the "AMA" group to compare AST, ALT, gamma-GT, and IgG quantification values (Table 4). This evidence concerns the gene GPT and autoimmune hepatitis.